Free Trial

Aileron Therapeutics (ALRN) Earnings Date, Estimates & Call Transcripts

Aileron Therapeutics logo
$2.73 -0.03 (-1.09%)
(As of 10:00 AM ET)

Aileron Therapeutics Latest Earnings Summary

Latest
Earnings Date
Aug. 14Estimated
Actual EPS
(Aug. 14)
-$0.45 Missed By -$0.20
Consensus EPS
(Aug. 14)
-$0.25

Aileron Therapeutics announced Q2 2024 earnings on August 14, 2024, reporting an EPS of -$0.45, which missed analysts' consensus estimates of -$0.25 by $0.20. With a trailing EPS of -$3.12, Aileron Therapeutics' earnings are expected to grow next year, from ($1.56) to ($1.41) per share.

Get Aileron Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aileron Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ALRN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALRN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aileron Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q4 20241-$0.15-$0.15-$0.15

Aileron Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
8/14/2024--$0.25-$0.45 -$0.20-$0.45--  
5/20/2024--$0.14-$0.86 -$0.72-$0.86--
4/15/2024Q4 2023--$1.54 -$1.54-$1.54--  
10/13/2023Q3 2023--$0.40 -$0.40-$0.40--
8/11/2023Q2 2023--$0.39 -$0.39-$0.39--
5/8/2023Q1 2023--$0.82 -$0.82-$0.59--

Aileron Therapeutics Earnings - Frequently Asked Questions

Aileron Therapeutics (NASDAQ:ALRN) last announced its quarterly earning data on Wednesday, August 14, 2024. Learn more on ALRN's earnings history.

In the previous quarter, Aileron Therapeutics (NASDAQ:ALRN) missed the analysts' consensus estimate of ($0.25) by $0.20 with a reported earnings per share (EPS) of ($0.45). Learn more on analysts' earnings estimate vs. ALRN's actual earnings.

Aileron Therapeutics (NASDAQ:ALRN) has a recorded net income of -$15.73 million. ALRN has generated -$3.12 earnings per share over the last four quarters.

Aileron Therapeutics's earnings are expected to grow from ($1.56) per share to ($1.41) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:ALRN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners